Medical Billing & Credentialing Services | Prohealthcare Advisors
Effective January 1, 2026, CMS deleted the C5271–C5278 skin substitute code series and reclassified cellular/tissue-based products (CTPs) under CPT 15271–15278 with new Q-code billing. Combined with mandatory KX/JW/JZ modifier use and stricter 4-week conservative-care documentation requirements, this is the largest single change to wound care billing in over a decade — and claims still using old C-codes are being denied outright.

All skin substitute graft applications must now be billed under CPT 15271–15278 regardless of clinical setting. Any claim still submitted with the old deleted C-codes is rejected outright — this took effect January 1, 2026 and is not a future change.
JW reports discarded graft material, JZ confirms zero waste, and KX attests medical necessity for use beyond the fourth application. Medicare now allows no more than eight skin substitute applications within a 12–16 week window — with mandatory healing-progress documentation at each one.
Most MACs withdrew their skin substitute-specific LCD checklists in early 2026, even though the underlying documentation requirements — wound measurements, 4-week conservative care trials, vascular assessments — still apply under general medical necessity standards.
Beyond the skin substitute overhaul, we manage standard wound care credentialing needs: license renewal tracking, monthly OIG/SAM exclusion checks, and documentation alignment with current health-equity and network filing rules. For practices billing hyperbaric oxygen therapy or debridement codes alongside CTP applications, we verify modifier 25 compliance whenever E/M is reported the same day as treatment — a common denial trigger under the new rules.
We already rebuilt our clients' charge masters for the CPT 15271–15278 transition — let us check yours.
Request a Free AR Assessment →